Harvard Medical School: Old Drugs and COVID-19
June 18, 2020
June 18, 2020
BOSTON, Massachusetts, June 18 -- Harvard Medical School issued the following news:
This article is part of Harvard Medical School's continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.
The U.S. Defense Advanced Research Projects Agency (DARPA) has signed an agreement worth up to $16 million over the next year with the Wyss Institute for Biologically Inspired Engineering at Harvar . . .
This article is part of Harvard Medical School's continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.
The U.S. Defense Advanced Research Projects Agency (DARPA) has signed an agreement worth up to $16 million over the next year with the Wyss Institute for Biologically Inspired Engineering at Harvar . . .